Management of Asymptomatic Arrhythmias: A European Heart Rhythm Association (EHRA) Consensus Document

March 18, 2019—Asymptomatic arrhythmias are frequently encountered in clinical practice. Although studies specifically dedicated to these asymptomatic arrhythmias are lacking, many arrhythmias still require proper diagnostic and prognostic evaluation and treatment to avoid severe consequences, such as stroke or systemic emboli, heart failure, or sudden cardiac death.

Given that the approach to asymptomatic arrhythmias is neither particularly clear nor straightforward, the European Heart Rhythm Association (EHRA), in collaboration with the Heart Failure Association (HFA), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Cardiac Arrhythmia Society of Southern Africa (CASSA), and the Latin American Heart Rhythm Society (LAHRS), convened a Task Force to review the clinical management of specific types of asymptomatic arrhythmias. The goal was to emphasize evidence-based approaches for risk stratification and appropriate pharmacological or nonpharmacological treatments, where evidence exists for asymptomatic arrhythmias.

The Heart Rhythm Society endorsed the document on February 11, 2019.